The Lancet Respiratory Medicine · 2026
Infectious diseases
Citation for Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial
Van Rie, A., Conceição, E.C., Ndebele, F., Wells, F., Paulse, A., Mekonnen, E.G., Ngarega, M., Trang, T.P.H., Bohlela, S., Sibeko, Z., Segwaba, P., Verboven, L., Heupink, T.H., Fuertes, M.D.D., Rennie, V., Dippenaar, A., Rigouts, L., Setlhare, L., Ogunbayo, A.E., VanderSpoel Van Dyk, A., Conradie, F., Maartens, G., Potgieter, S., Black, J., Fanampe, B., Abrams, S., Churchyard, G., Warren, R., & Charalambous, S. (2026) "Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial." The Lancet Respiratory Medicine. 14(6), 521–532.
EPIDEMICS · 2026
Citation for Population-level associations in the spread of co-circulating respiratory viruses: A multi-method statistical investigation using incidence data
Barth, Nadine; Carstens, Gesa; Kozanli, Eva; Han , Wanda; Hermans, Lisa; Paolotti, Daniela; Abrams, Steven; Molenberghs, Geert; Hens, Niel; Faes, Christel; Eggink, Dirk; Van Hoek, Albert Jan; Torneri, Andrea. (2026). Population-level associations in the spread of co-circulating respiratory viruses: A multi-method statistical investigation using incidence data. EPIDEMICS.
Journal of Statistical Planning and Inference · 2026
Statistical methods
Citation for Nonparametric estimation of the quantiles of the conditional residual lifetime distribution
Abrams, S., Janssen, P., & Veraverbeke, N. (2026) "Nonparametric estimation of the quantiles of the conditional residual lifetime distribution." Journal of Statistical Planning and Inference. 243, 106373.
Eurosurveillance · 2026
Infectious diseases
Citation for Informing quarantine policy for measles control in primary school and daycare settings: insights from a simulation study, Flanders, Belgium
Kremer, C., Hammami, N., Cornelissen, L., Theeten, H., Braeye, T., Torneri, A., Abrams, S., & Hens, N. (2026) "Informing quarantine policy for measles control in primary school and daycare settings: insights from a simulation study, Flanders, Belgium." Eurosurveillance. 31(22).
PLOS ONE · 2026
Infectious diseases · Immunity and vaccination · Statistical methods
Citation for Factors influencing SARS-CoV-2 IgG test sensitivity: A Bayesian analysis of seroconversion and seroreversion by time since infection, test, age and disease severity
Braeye, T., Abrams, S., & Hens, N. (2026) "Factors influencing SARS-CoV-2 IgG test sensitivity: A Bayesian analysis of seroconversion and seroreversion by time since infection, test, age and disease severity." PLOS ONE. 21(2), e0328144.
Archives of Public Health · 2026
Infectious diseases · Immunity and vaccination
Citation for Estimating the incidence of SARS-CoV-2 infections by jointly modelling seroprevalence, hospitalization and mortality data, February 2020-January 2021, Belgium
Braeye, T., De Pauw, R., Geebelen, L., Abrams, S., Desombere, I., Hens, N., Hammami, N., Roelants, M., Muylaert, A., & Herzog, S.A. (2026) "Estimating the incidence of SARS-CoV-2 infections by jointly modelling seroprevalence, hospitalization and mortality data, February 2020-January 2021, Belgium." Archives of Public Health. 84(1).
BMC Infectious Diseases · 2026
Infectious diseases
Citation for Decentralizing care for cutaneous leishmaniasis and other skin diseases to primary health facilities in Southern Ethiopia: What are the needs?
Tadesse, D., Henten, S., Batire, S., Woge, M.T., Degaga, T.S., Merdekios, B., Abrams, S., Hailu, A., Geertruyden, J.P.V., Griensven, J., & Pareyn, M. (2026) "Decentralizing care for cutaneous leishmaniasis and other skin diseases to primary health facilities in Southern Ethiopia: What are the needs?." BMC Infectious Diseases. 26(1).
International journal of nursing studies · 2026
Citation for Corrigendum to “Beyond staffing ratios - team demographic diversity, workforce stability, and their effects on patient safety and workforce sustainability: A multi-country analysis” [Int. J. Nurs. Stud. 181 (2026) 105570]
Vleminckx, Senne; De Meulenaere, Kim; Van Bogaert, Peter; ABRAMS, Steven; WILLEM, Lander; Haegdorens, Filip. (2026). Corrigendum to “Beyond staffing ratios - team demographic diversity, workforce stability, and their effects on patient safety and workforce sustainability: A multi-country analysis” [Int. J. Nurs. Stud. 181 (2026) 105570]. International journal of nursing studies.
International Journal of Nursing Studies · 2026
Clinical and public health research
Citation for Beyond staffing ratios-team demographic diversity, workforce stability, and their effects on patient safety and workforce sustainability: A multi-country analysis
Vleminckx, S., De Meulenaere, K., Van Bogaert, P., Abrams, S., Willem, L., & Haegdorens, F. (2026) "Beyond staffing ratios-team demographic diversity, workforce stability, and their effects on patient safety and workforce sustainability: A multi-country analysis." International Journal of Nursing Studies. 181, 105570.
Dependence Modeling · 2026
Statistical methods
Citation for Bernstein–based Nonparametric Estimation of the Cross Ratio Function under Univariate Right Censoring
Sercik, Ö., Abrams, S., & Verhasselt, A. (2026) "Bernstein–based Nonparametric Estimation of the Cross Ratio Function under Univariate Right Censoring." Dependence Modeling. 14(1).
Archives of public health · 2026
Citation for A scoping review of COVID-19 modelling studies in Belgium 2020-2024: incorporation of behaviour and lessons learned
BAGAFORO, Roel Jude; DUPAS, Marie-Cécile; ABRAMS, Steven; Dellicour, Simon; HENS, Niel. (2026). A scoping review of COVID-19 modelling studies in Belgium 2020-2024: incorporation of behaviour and lessons learned. Archives of public health.
Vaccine · 2025
Immunity and vaccination
Citation for Within-host mathematical models to study antibody kinetics after the prophylactic Ebola vaccine in the Democratic Republic of the Congo
Garcia-Fogeda, I., Abrams, S., Vanhee, S., Salloum, M., Ogunjimi, B., & Hens, N. (2025) "Within-host mathematical models to study antibody kinetics after the prophylactic Ebola vaccine in the Democratic Republic of the Congo." Vaccine. 64, 127707.
The Lancet Digital Health · 2025
Immunity and vaccination
Citation for Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study
Gonzalez Dorta, H., Verbeeck, J., Crevecoeur, J., Morales, D.R., Loedy, N., Cohet, C., Willem, L., Molenberghs, G., Hens, N., Kurz, X., Quinten, C., & Abrams, S. (2025) "Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study." The Lancet Digital Health. 7(5), 100861.
Journal of Medical Virology · 2025
Infectious diseases · Immunity and vaccination
Citation for Systematic Molecular Influenza A/B Screening Upon Hospital Admission in Belgium, January-April 2022: Positivity Ratios and Viral Loads According to Symptomatology, Age, and Vaccination Status
Huyghe, E., Abrams, S., André, E., Anseeuw, K., Bernaert, E., Bruynseels, P., Cuypers, L., De Schouwer, P., Hilkens, P., Keyaerts, E., Laenen, L., Maes, J., Magerman, K., Van de gaer, O., Verdonck, A., Verstrepen, W., Ombelet, S., & Naesens, R. (2025) "Systematic Molecular Influenza A/B Screening Upon Hospital Admission in Belgium, January-April 2022: Positivity Ratios and Viral Loads According to Symptomatology, Age, and Vaccination Status." Journal of Medical Virology. 97(1).
BMC Medical Research Methodology · 2025
Infectious diseases · Statistical methods
Citation for Improving the efficiency of drug resistant tuberculosis treatment trials: a time-to-event alternative marker for bacteriological response and adaptive minimization for randomization
De Vos, E., Van Rie, A., & Abrams, S. (2025) "Improving the efficiency of drug resistant tuberculosis treatment trials: a time-to-event alternative marker for bacteriological response and adaptive minimization for randomization." BMC Medical Research Methodology. 25(1).
Scientific Reports · 2025
Infectious diseases · Immunity and vaccination
Citation for Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients
Debie, Y., Garcia-Fogeda, I., Willem, L., Roelant, E., Verbruggen, L., Vanhoutte, G., Croes, L., Vulsteke, C., Demey, W., Lybaert, W., Hanssens, M., Bols, A., Van ongeval, J., De Becker, A., Jansens, H., Goossens, M.E., Janssens, A., Prenen, H., Anguille, S., Peeters, M., van Dam, P.A., Hens, N., Abrams, S., & Vandamme, T. (2025) "Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients." Scientific Reports. 15(1).
Renewable and Sustainable Energy Reviews · 2025
Clinical and public health research
Citation for Charcoal and firewood use in urban areas of developing countries: Drivers, consequences, and the need for clean cooking solutions
Balume, B.S., Bijnens, L., Abrams, S., Banza, B.B., & Deferme, W. (2025) "Charcoal and firewood use in urban areas of developing countries: Drivers, consequences, and the need for clean cooking solutions." Renewable and Sustainable Energy Reviews. 217, 115745.
Nature Communications · 2025
Infectious diseases
Citation for Assessing the role of children in the COVID-19 pandemic in Belgium using perturbation analysis
Angeli, L., Caetano, C.P., Franco, N., Coletti, P., Faes, C., Molenberghs, G., Beutels, P., Abrams, S., Willem, L., & Hens, N. (2025) "Assessing the role of children in the COVID-19 pandemic in Belgium using perturbation analysis." Nature Communications. 16(1).
BMC Health Services Research · 2025
Clinical and public health research
Citation for Assessing the capacity of primary healthcare facilities and healthcare workers in managing diabetes and hypertension in Kisumu county, Kenya
Ouma, O.J., Omondi, D., Museve, E., Owenga, J., Bogers, J., Abrams, S., & van Olmen, J. (2025) "Assessing the capacity of primary healthcare facilities and healthcare workers in managing diabetes and hypertension in Kisumu county, Kenya." BMC Health Services Research. 25(1).
Malaria Journal · 2025
Infectious diseases
Citation for An integrative review of the combined use of mathematical and statistical models for estimating malaria transmission parameters
Grosso, A., Hens, N., & Abrams, S. (2025) "An integrative review of the combined use of mathematical and statistical models for estimating malaria transmission parameters." Malaria Journal. 24(1).
European Journal of Public Health · 2025
Immunity and vaccination
Citation for An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union
Loedy, N., Dorta, H.G., Abrams, S., Crèvecoeur, J., Morales, D.R., Cohet, C., Willem, L., Molenberghs, G., Hens, N., Kurz, X., Quinten, C., & Verbeeck, J. (2025) "An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union." European Journal of Public Health. 35(5), 1007–1013.
South African Statistical Journal · 2025
Infectious diseases · Statistical methods
Citation for A Bayesian mixture model accounting for individual heterogeneity in response to pathogenic infection
Martins, A., Hens, N., & Abrams, S. (2025) "A Bayesian mixture model accounting for individual heterogeneity in response to pathogenic infection." South African Statistical Journal. 59(1), 37–58.
Journal of Theoretical Biology · 2024
Infectious diseases
Citation for Who acquires infection from whom? A sensitivity analysis of transmission dynamics during the early phase of the COVID-19 pandemic in Belgium
Angeli, L., Caetano, C.P., Franco, N., Abrams, S., Coletti, P., Van Nieuwenhuyse, I., Pop, S., & Hens, N. (2024) "Who acquires infection from whom? A sensitivity analysis of transmission dynamics during the early phase of the COVID-19 pandemic in Belgium." Journal of Theoretical Biology. 581, 111721.
Cureus Journal of Medical Science · 2024
Clinical and public health research
Citation for Types and Effectiveness of Community-Based Cardiovascular Disease Preventive Interventions in Reducing Alcohol Consumption: A Systematic Review and Meta-Analysis
Berhe, N.M., Hassen, H.Y., Van Geertruyden, J.P., Ndejjo, R., Musinguzi, G., Bastiaens, H., & Abrams, S. (2024) "Types and Effectiveness of Community-Based Cardiovascular Disease Preventive Interventions in Reducing Alcohol Consumption: A Systematic Review and Meta-Analysis." Cureus Journal of Medical Science.
Journal of Crohn's and colitis · 2024
Clinical and public health research
Citation for The Intestinal Mucin Isoform Landscape Reveals Region- Specific Biomarker Panels for Inflammatory Bowel Disease Patient Stratification
Arras, W., Breugelmans, T., Oosterlinck, B., De Man, J.G., Malhotra-Kumar, S., Abrams, S., Van Laere, S., Macken, E., Somers, M., Jauregui-Amezaga, A., De Winter, B.Y., & Smet, A. (2024) "The Intestinal Mucin Isoform Landscape Reveals Region- Specific Biomarker Panels for Inflammatory Bowel Disease Patient Stratification." Journal of Crohn's and Colitis. 19(3).
BMC Public Health · 2024
Infectious diseases · Immunity and vaccination
Citation for The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022)
Willem, L., Abrams, S., Franco, N., Coletti, P., Libin, P.J.K., Wambua, J., Couvreur, S., André, E., Wenseleers, T., Mao, Z., Torneri, A., Faes, C., Beutels, P., & Hens, N. (2024) "The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022)." BMC Public Health. 24(1).
BMC Infectious Diseases · 2024
Infectious diseases · Immunity and vaccination
Citation for Predictors of moderate-to-severe side-effects following COVID-19 mRNA booster vaccination: a prospective cohort study among primary health care providers in Belgium
Domen, J., Abrams, S., Digregorio, M., Van Ngoc, P., Duysburgh, E., Scholtes, B., & Coenen, S. (2024) "Predictors of moderate-to-severe side-effects following COVID-19 mRNA booster vaccination: a prospective cohort study among primary health care providers in Belgium." BMC Infectious Diseases. 24(1).
Expert Systems With Applications · 2024
Infectious diseases
Citation for Exploring the Pareto front of multi-objective COVID-19 mitigation policies using reinforcement learning
Reymond, M., Hayes, C.F., Willem, L., Rădulescu, R., Abrams, S., Roijers, D.M., Howley, E., Mannion, P., Hens, N., Nowé, A., & Libin, P. (2024) "Exploring the Pareto front of multi-objective COVID-19 mitigation policies using reinforcement learning." Expert Systems With Applications. 249, 123686.
Epidemics · 2024
Infectious diseases
Citation for Characterising information gains and losses when collecting multiple epidemic model outputs
Sherratt, K., Srivastava, A., Ainslie, K., Singh, D.E., Cublier, A., Marinescu, M.C., Carretero, J., Garcia, A.C., Franco, N., Willem, L., Abrams, S., Faes, C., Beutels, P., Hens, N., Müller, S., Charlton, B., Ewert, R., Paltra, S., Rakow, C., Rehmann, J., Conrad, T., Schütte, C., Nagel, K., Abbott, S., Grah, R., Niehus, R., Prasse, B., Sandmann, F., & Funk, S. (2024) "Characterising information gains and losses when collecting multiple epidemic model outputs." Epidemics. 47, 100765.
Statistics · 2024
Statistical methods
Citation for Bernstein-based estimation of the cross ratio function
Abrams, S., Sercik, Ö., & Veraverbeke, N. (2024) "Bernstein-based estimation of the cross ratio function." Statistics. 58(1), 230–246.
Vaccine · 2023
Infectious diseases · Immunity and vaccination
Citation for Within-host modeling to measure dynamics of antibody responses after natural infection or vaccination: A systematic review
Garcia-Fogeda, I., Besbassi, H., Larivière, Y., Ogunjimi, B., Abrams, S., & Hens, N. (2023) "Within-host modeling to measure dynamics of antibody responses after natural infection or vaccination: A systematic review." Vaccine. 41(25), 3701–3709.
BMC Infectious Diseases · 2023
Infectious diseases
Citation for The impact of national and international travel on spatio-temporal transmission of SARS-CoV-2 in Belgium in 2021
Nguyen, M.H., Nguyen, T.H.T., Molenberghs, G., Abrams, S., Hens, N., & Faes, C. (2023) "The impact of national and international travel on spatio-temporal transmission of SARS-CoV-2 in Belgium in 2021." BMC Infectious Diseases. 23(1).
BMC Public Health · 2023
Infectious diseases
Citation for The direct disease burden of COVID-19 in Belgium in 2020 and 2021
Devleesschauwer, B., Willem, L., Jurčević, J., Smith, P., Scohy, A., Wyper, G.M.A., Pires, S.M., Van Goethem, N., Beutels, P., Franco, N., Abrams, S., Van Cauteren, D., Speybroeck, N., Hens, N., & De Pauw, R. (2023) "The direct disease burden of COVID-19 in Belgium in 2020 and 2021." BMC Public Health. 23(1).
Frontiers in Immunology · 2023
Immunity and vaccination
Citation for Modeling antibody dynamics following herpes zoster indicates that higher varicella-zoster virus viremia generates more VZV-specific antibodies
Besbassi, H., Garcia-Fogeda, I., Quinlivan, M., Breuer, J., Abrams, S., Hens, N., Ogunjimi, B., & Beutels, P. (2023) "Modeling antibody dynamics following herpes zoster indicates that higher varicella-zoster virus viremia generates more VZV-specific antibodies." Frontiers in Immunology. 14.
European Journal of Cancer Prevention · 2023
Immunity and vaccination
Citation for Evolution of human papilloma virus prevalence in a highly vaccinated region in Belgium: a retrospective cohort study in Flemish women (2010-2019)
Huyghe, E., Abrams, S., Bogers, J.P., Verhoeven, V., & Benoy, I. (2023) "Evolution of human papilloma virus prevalence in a highly vaccinated region in Belgium: a retrospective cohort study in Flemish women (2010-2019)." European Journal of Cancer Prevention. 32(1), 48–56.
European Heart Journal · 2023
Clinical and public health research
Citation for Disparities in the non-laboratory INTERHEART risk score and its components in selected countries of Europe and sub-Saharan Africa: analysis from the SPICES multi-country project
Hassen, H.Y., Abrams, S., Musinguzi, G., Rogers, I., Dusabimana, A., Mphekgwana, P.M., Bastiaens, H., Bastiaens, H., Hassen, H.Y., Aerts, N., Anthierens, S., Van Royen, K., Masquillier, C., Le Reste, J.Y., Le Goff, D., Perraud, G., van Marwijk, H., Ford, E., Grice-Jackson, T., Rogers, I., Nahar, P., Gibson, L., Bowyer, M., Nkengateh, A., Musinguzi, G., Ndejjo, R., Nuwaha, F., Sodi, T., Mphekgwana, P.M., Malema, N., Kgatla, N., & Mothiba, T.M. (2023) "Disparities in the non-laboratory INTERHEART risk score and its components in selected countries of Europe and sub-Saharan Africa: analysis from the SPICES multi-country project." European Heart Journal. 3(6).
Public Health Nutrition · 2023
Clinical and public health research
Citation for Dietary outcomes of community-based cardiovascular disease preventive interventions: a systematic review and meta-analysis
Hassen, H.Y., Sisay, B.G., Van Geertruyden, J.P., Le Goff, D., Ndejjo, R., Musinguzi, G., Abrams, S., & Bastiaens, H. (2023) "Dietary outcomes of community-based cardiovascular disease preventive interventions: a systematic review and meta-analysis." Public Health Nutrition. 26(11), 2480–2491.
Pharmacoepidemiology and Drug Safety · 2023
Infectious diseases · Immunity and vaccination
Citation for A digital toolkit to contextualize and visualize the benefit and risk of COVID-19 vaccines in the European union
(2023) "A digital toolkit to contextualize and visualize the benefit and risk of COVID-19 vaccines in the European union." Pharmacoepidemiology and Drug Safety. 32(S1), 3–612.
PLOS ONE · 2023
Statistical methods
Citation for A Bayesian approach to estimate the probability of resistance to bedaquiline in the presence of a genomic variant
Anlay, D.Z., Rivière, E., Tu, P.H.T., Abrams, S., & Van Rie, A. (2023) "A Bayesian approach to estimate the probability of resistance to bedaquiline in the presence of a genomic variant." PLOS ONE. 18(6), e0287019.
American Journal of Preventive Cardiology · 2022
Clinical and public health research
Citation for Type and effectiveness of community-based interventions in improving knowledge related to cardiovascular diseases and risk factors: A systematic review
Hassen, H.Y., Ndejjo, R., Van Geertruyden, J.P., Musinguzi, G., Abrams, S., & Bastiaens, H. (2022) "Type and effectiveness of community-based interventions in improving knowledge related to cardiovascular diseases and risk factors: A systematic review." American Journal of Preventive Cardiology. 10, 100341.
Frontiers in Pharmacology · 2022
Clinical and public health research
Citation for The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult
Ceuleers, H., Hanning, N., De bruyn, M., De Man, J.G., De Schepper, H.U., Li, Q., Liu, L., Abrams, S., Smet, A., Joossens, J., Augustyns, K., De Meester, I., Pasricha, P.J., & De Winter, B.Y. (2022) "The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult." Frontiers in Pharmacology. 13.
Pathogens · 2022
Infectious diseases
Citation for Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening
Dusabimana, A., Siewe Fodjo, J.N., Ndahura, M.M., Mmbando, B.P., Jada, S.R., Boven, A., De Smet, E., Ukety, T., Njamnshi, A.K., Laudisoit, A., Abrams, S., & Colebunders, R. (2022) "Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening." Pathogens. 11(3), 281.
Eurosurveillance · 2022
Infectious diseases · Immunity and vaccination
Citation for Seroprevalence of IgG antibodies against SARS-CoV-2 – a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020
Herzog, S.A., De Bie, J., Abrams, S., Wouters, I., Ekinci, E., Patteet, L., Coppens, A., De Spiegeleer, S., Beutels, P., Van Damme, P., Hens, N., & Theeten, H. (2022) "Seroprevalence of IgG antibodies against SARS-CoV-2 – a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020." Eurosurveillance. 27(9).
Nephrology Dialysis Transplantation · 2022
Immunity and vaccination
Citation for Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis
Verleye, A., Wijtvliet, V., Abrams, S., Hellemans, R., Bougrea, R., Massart, A., Pipeleers, L., Wissing, K.M., Ariën, K.K., De Winter, B.Y., Van Damme, P., Abramowicz, D., & Ledeganck, K.J. (2022) "Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis." Nephrology Dialysis Transplantation. 37(8), 1566–1575.
Trials · 2022
Infectious diseases
Citation for Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial
Van Rie, A., De Vos, E., Costa, E., Verboven, L., Ndebele, F., Heupink, T.H., Abrams, S., Maraba, N., Makkan, H., Beattie, T., Sibeko, Z.R., Bohlela, S., Segwaba, P., Ogunbayo, E.A., Mhlambi, N., Wells, F., Rigouts, L., Maartens, G., Conradie, F., Black, J., Potgieter, S., Fanampe, B., Van der Spoel Van Dyk, A., Charalambous, S., Churchyard, G., & Warren, R. (2022) "Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial." Trials. 23(1).
Transplant Immunology · 2022
Infectious diseases · Immunity and vaccination
Citation for SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies
Wijtvliet, V.P.W.M., Verheyden, S., Depreter, B., Heylen, C., Coeman, E., Abrams, S., De Winter, B.Y., Massart, A., Hellemans, R., Pipeleers, L., Claas, F.H.J., Ariën, K.K., Wissing, K.M., Abramowicz, D., & Ledeganck, K.J. (2022) "SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies." Transplant Immunology. 74, 101670.
Journal of Infection and Chemotherapy · 2022
Infectious diseases
Citation for Predicting mortality in intensive care unit patients infected with Klebsiella pneumoniae: A retrospective cohort study
Tran, T.N., Vu, D.H., Nguyen, H.A., Abrams, S., Bruyndonckx, R., Nguyen, T.T., Tran, N.M., Trinh, T.A., Do, T.H.G., Pham, H.N., Nguyen, G.B., & Coenen, S. (2022) "Predicting mortality in intensive care unit patients infected with Klebsiella pneumoniae: A retrospective cohort study." Journal of Infection and Chemotherapy. 28(1), 10–18.
Journal of Nonparametric Statistics · 2022
Statistical methods
Citation for Nonparametric estimation of risk ratios for bivariate data
Abrams, S., Janssen, P., Swanepoel, J., & Veraverbeke, N. (2022) "Nonparametric estimation of risk ratios for bivariate data." Journal of Nonparametric Statistics. 34(4), 940–963.
JAC-Antimicrobial Resistance · 2022
Clinical and public health research
Citation for Nationwide implementation of online communication skills training to reduce overprescribing of antibiotics: a stepped-wedge cluster randomized trial in general practice
D’Hulster, L., Abrams, S., Bruyndonckx, R., Anthierens, S., Adriaenssens, N., Butler, C.C., Verheij, T., Goossens, H., Little, P., & Coenen, S. (2022) "Nationwide implementation of online communication skills training to reduce overprescribing of antibiotics: a stepped-wedge cluster randomized trial in general practice." JAC-Antimicrobial Resistance. 4(3).
Nephrology Dialysis Transplantation · 2022
Immunity and vaccination
Citation for mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?
Wijtvliet, V.P.W.M., Ariën, K.K., Abrams, S., Couttenye, M.M., Mestrez, F., Mariën, J., De Winter, B.Y., Van Damme, P., Pipeleers, L., Wissing, K.M., Abramowicz, D., & Ledeganck, K.J. (2022) "mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?." Nephrology Dialysis Transplantation. 37(4), 799–803.
Malaria Journal · 2022
Infectious diseases · Statistical methods
Citation for Modelling longitudinal binary outcomes with outcome dependent observation times: an application to a malaria cohort study
Martins, A., Herzog, S.A., Mugenyi, L., Faes, C., Hens, N., & Abrams, S. (2022) "Modelling longitudinal binary outcomes with outcome dependent observation times: an application to a malaria cohort study." Malaria Journal. 21(1).
BMC Public Health · 2022
Clinical and public health research
Citation for Level of cardiovascular disease knowledge, risk perception and intention towards healthy lifestyle and socioeconomic disparities among adults in vulnerable communities of Belgium and England
Hassen, H.Y., Bowyer, M., Gibson, L., Abrams, S., & Bastiaens, H. (2022) "Level of cardiovascular disease knowledge, risk perception and intention towards healthy lifestyle and socioeconomic disparities among adults in vulnerable communities of Belgium and England." BMC Public Health. 22(1).
PLOS Computational Biology · 2022
Infectious diseases
Citation for Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data
Franco, N., Coletti, P., Willem, L., Angeli, L., Lajot, A., Abrams, S., Beutels, P., Faes, C., & Hens, N. (2022) "Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data." PLOS Computational Biology. 18(3), e1009965.
Vaccine · 2022
Infectious diseases · Immunity and vaccination
Citation for Identifying immunity gaps for measles using Belgian serial serology data
Schenk, J., Abrams, S., Litzroth, A., Cornelissen, L., Grammens, T., Theeten, H., & Hens, N. (2022) "Identifying immunity gaps for measles using Belgian serial serology data." Vaccine. 40(26), 3676–3683.
Breast Cancer Research and Treatment · 2022
Clinical and public health research
Citation for Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trial
Braal, C.L., Westenberg, J.D., Buijs, S.M., Abrams, S., Mulder, T.A.M., van Schaik, R.H.N., Koolen, S.L.W., Jager, A., & Mathijssen, R.H.J. (2022) "Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trial." Breast Cancer Research and Treatment. 195(1), 65–74.
PLOS Computational Biology · 2022
Infectious diseases · Statistical methods
Citation for Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2
Kuylen, E.J., Torneri, A., Willem, L., Libin, P.J.K., Abrams, S., Coletti, P., Franco, N., Verelst, F., Beutels, P., Liesenborgs, J., & Hens, N. (2022) "Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2." PLOS Computational Biology. 18(8), e1009980.
Eurosurveillance · 2022
Infectious diseases
Citation for COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020
Molenberghs, G., Faes, C., Verbeeck, J., Deboosere, P., Abrams, S., Willem, L., Aerts, J., Theeten, H., Devleesschauwer, B., Bustos Sierra, N., Renard, F., Herzog, S., Lusyne, P., Van der Heyden, J., Van Oyen, H., Van Damme, P., & Hens, N. (2022) "COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020." Eurosurveillance. 27(7).
Pathogens · 2022
Infectious diseases
Citation for Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11 , 281
Dusabimana, A., Siewe Fodjo, J.N., Ndahura, M.M., Mmbando, B.P., Jada, S.R., Boven, A., De Smet, E., Ukety, T., Njamnshi, A.K., Laudisoit, A., Abrams, S., & Colebunders, R. (2022) "Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11 , 281." Pathogens. 11(7), 746.
Scientific Reports · 2021
Clinical and public health research
Citation for Validation of the Dutch-Flemish translated ABCD questionnaire to measure cardiovascular diseases knowledge and risk perception among adults
Hassen, H.Y., Aerts, N., Demarest, S., Manzar, M.D., Abrams, S., & Bastiaens, H. (2021) "Validation of the Dutch-Flemish translated ABCD questionnaire to measure cardiovascular diseases knowledge and risk perception among adults." Scientific Reports. 11(1).
Nature Communications · 2021
Infectious diseases
Citation for The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19
Willem, L., Abrams, S., Libin, P.J.K., Coletti, P., Kuylen, E., Petrof, O., Møgelmose, S., Wambua, J., Herzog, S.A., Faes, C., Beutels, P., & Hens, N. (2021) "The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19." Nature Communications. 12(1).
Statistics · 2021
Statistical methods
Citation for Quantiles of the conditional residual lifetime
Abrams, S., Janssen, P., & Veraverbeke, N. (2021) "Quantiles of the conditional residual lifetime." Statistics. 55(6), 1271–1290.
Epidemics · 2021
Infectious diseases
Citation for Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories
Abrams, S., Wambua, J., Santermans, E., Willem, L., Kuylen, E., Coletti, P., Libin, P., Faes, C., Petrof, O., Herzog, S.A., Beutels, P., & Hens, N. (2021) "Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories." Epidemics. 35, 100449.
Statistics in Medicine · 2021
Immunity and vaccination · Statistical methods
Citation for Measuring association among censored antibody titer data
Tran, T.M.P., Abrams, S., Aerts, M., Maertens, K., & Hens, N. (2021) "Measuring association among censored antibody titer data." Statistics in Medicine. 40(16), 3740–3761.
The Lancet Infectious Diseases · 2021
Infectious diseases · Immunity and vaccination
Citation for Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis
Schenk, J., Abrams, S., Theeten, H., Van Damme, P., Beutels, P., & Hens, N. (2021) "Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis." The Lancet Infectious Diseases. 21(2), 286–295.
PLOS ONE · 2021
Infectious diseases
Citation for Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium
Heireman, L., Abrams, S., Bruynseels, P., Cartuyvels, R., Cuypers, L., De Schouwer, P., Laffut, W., Lagrou, K., Hens, N., Ho, E., Padalko, E., Reynders, M., Vandamme, S., Van der Moeren, N., Verstrepen, W., Willems, P., & Naesens, R. (2021) "Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium." PLOS ONE. 16(11), e0259908.
PLOS ONE · 2021
Clinical and public health research
Citation for Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy
Geens, M., Stappers, S., Konings, H., De Winter, B.Y., Specenier, P., Van Meerbeeck, J.P., Verpooten, G.A., Abrams, S., Janssens, A., Peeters, M., Van de Heyning, P., Vanderveken, O.M., & Ledeganck, K.J. (2021) "Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy." PLOS ONE. 16(6), e0252646.
Preventive Medicine · 2021
Clinical and public health research
Citation for Effectiveness of community-based cardiovascular disease prevention interventions to improve physical activity: A systematic review and meta-regression
Hassen, H.Y., Ndejjo, R., Musinguzi, G., Van Geertruyden, J.P., Abrams, S., & Bastiaens, H. (2021) "Effectiveness of community-based cardiovascular disease prevention interventions to improve physical activity: A systematic review and meta-regression." Preventive Medicine. 153, 106797.
Public Health Reviews · 2021
Clinical and public health research
Citation for Community-Based Interventions for Cardiovascular Disease Prevention in Low-and Middle-Income Countries: A Systematic Review
Ndejjo, R., Hassen, H.Y., Wanyenze, R.K., Musoke, D., Nuwaha, F., Abrams, S., Bastiaens, H., & Musinguzi, G. (2021) "Community-Based Interventions for Cardiovascular Disease Prevention in Low-and Middle-Income Countries: A Systematic Review." Public Health Reviews. 42.
BMC Infectious Diseases · 2021
Infectious diseases
Citation for A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies
Coletti, P., Libin, P., Petrof, O., Willem, L., Abrams, S., Herzog, S.A., Faes, C., Kuylen, E., Wambua, J., Beutels, P., & Hens, N. (2021) "A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies." BMC Infectious Diseases. 21(1).
Pathogens · 2020
Infectious diseases
Citation for Urinary N-acetyltyramine-O,β-glucuronide in persons with onchocerciasis-associated epilepsy
Hotterbeekx, A., Dusabimana, A., Mandro, M., Abhafule, G.M., Deogratias, W.R., Siewe Fodjo, J.N., Abrams, S., & Colebunders, R. (2020) "Urinary N-acetyltyramine-O,β-glucuronide in persons with onchocerciasis-associated epilepsy." Pathogens. 9(3), 191.
Global Epidemiology · 2020
Clinical and public health research
Citation for Trends and determinants of health facility childbirth service utilization among mothers in urban slums of Nairobi, Kenya
Atahigwa, C., Kadengye, D.T., Iddi, S., Abrams, S., & Van Rie, A. (2020) "Trends and determinants of health facility childbirth service utilization among mothers in urban slums of Nairobi, Kenya." Global Epidemiology. 2, 100029.
International Journal of Environmental Research and Public Health · 2020
Infectious diseases
Citation for Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients
Faes, C., Abrams, S., Van Beckhoven, D., Meyfroidt, G., Vlieghe, E., & Hens, N. (2020) "Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients." International Journal of Environmental Research and Public Health. 17(20), 7560.
Nephrology Dialysis Transplantation · 2020
Clinical and public health research
Citation for The potential of donor-derived cell-free DNA as a biomarker for rejection in kidney transplantation: A systematic review and meta-analysis
Wijtvliet, V., Plaeke, P., Abrams, S., Hens, N., Gielis, E., Hellemans, R., De Winter, B., Abramowicz, D., & Ledeganck, K. (2020) "The potential of donor-derived cell-free DNA as a biomarker for rejection in kidney transplantation: A systematic review and meta-analysis." Nephrology Dialysis Transplantation. 35(Supplement_3): 190.
PLOS ONE · 2020
Clinical and public health research
Citation for Socioeconomic and behavioral determinants of cardiovascular diseases among older adults in Belgium and France: A longitudinal analysis from the SHARE study
Hassen, H.Y., Bastiaens, H., Van Royen, K., & Abrams, S. (2020) "Socioeconomic and behavioral determinants of cardiovascular diseases among older adults in Belgium and France: A longitudinal analysis from the SHARE study." PLOS ONE. 15(12), e0243422.
Pathogens · 2020
Infectious diseases
Citation for Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo
Mandro, M., Siewe Fodjo, J.N., Dusabimana, A., Mukendi, D., Haesendonckx, S., Lokonda, R., Nakato, S., Nyisi, F., Abhafule, G., Wonya’rossi, D., Hotterbeekx, A., Abrams, S., & Colebunders, R. (2020) "Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo." Pathogens. 9(3), 205.
Annals of the Institute of Statistical Mathematics · 2020
Statistical methods
Citation for Nonparametric estimation of the cross ratio function
Abrams, S., Janssen, P., Swanepoel, J., & Veraverbeke, N. (2020) "Nonparametric estimation of the cross ratio function." Annals of the Institute of Statistical Mathematics. 72(3), 771–801.
Pathogens · 2020
Infectious diseases
Citation for Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study
Dusabimana, A., Bhwana, D., Raimon, S., Mmbando, B.P., Hotterbeekx, A., Tepage, F., Mandro, M., Siewe Fodjo, J.N., Abrams, S., & Colebunders, R. (2020) "Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study." Pathogens. 9(8), 617.
Contemporary Clinical Trials · 2020
Infectious diseases
Citation for Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country
Molenberghs, G., Buyse, M., Abrams, S., Hens, N., Beutels, P., Faes, C., Verbeke, G., Van Damme, P., Goossens, H., Neyens, T., Herzog, S., Theeten, H., Pepermans, K., Abad, A.A., Van Keilegom, I., Speybroeck, N., Legrand, C., De Buyser, S., & Hulstaert, F. (2020) "Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country." Contemporary Clinical Trials. 99, 106189.
Journal of Antimicrobial Chemotherapy · 2020
Infectious diseases
Citation for Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: A retrospective case-control study
Chaname Pinedo, L.E., Bruyndonckx, R., Catry, B., Latour, K., Goossens, H., Abrams, S., & Coenen, S. (2020) "Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: A retrospective case-control study." Journal of Antimicrobial Chemotherapy. 75(7), 1985–1992.
Pathogens · 2020
Infectious diseases
Citation for Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with Onchocerca volvulus
Dusabimana, A., Tsebeni Wafula, S., Raimon, S.J., Fodjo, J.N.S., Bhwana, D., Tepage, F., Abd-Elfarag, G., Hotterbeekx, A., Abrams, S., & Colebunders, R. (2020) "Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with Onchocerca volvulus." Pathogens. 10(1), 21.
Transplant International · 2020
Clinical and public health research
Citation for Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta-analysis
Wijtvliet, V.P.W.M., Plaeke, P., Abrams, S., Hens, N., Gielis, E.M., Hellemans, R., Massart, A., Hesselink, D.A., De Winter, B.Y., Abramowicz, D., & Ledeganck, K.J. (2020) "Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta-analysis." Transplant International. 33(12), 1626–1642.
Pathogens · 2020
Infectious diseases
Citation for Comparison of Diagnostic Tests for Onchocerca volvulus in the Democratic Republic of Congo
Hotterbeekx, A., Perneel, J., Mandro, M., Abhafule, G., Siewe Fodjo, J.N., Dusabimana, A., Abrams, S., Kumar-Singh, S., & Colebunders, R. (2020) "Comparison of Diagnostic Tests for Onchocerca volvulus in the Democratic Republic of Congo." Pathogens. 9(6), 435.
Statistics in Medicine · 2020
Infectious diseases · Statistical methods
Citation for A general frailty model to accommodate individual heterogeneity in the acquisition of multiple infections: An application to bivariate current status data
Tran, T.M.P., Abrams, S., & Braekers, R. (2020) "A general frailty model to accommodate individual heterogeneity in the acquisition of multiple infections: An application to bivariate current status data." Statistics in Medicine. 39(12), 1695–1714.
Epidemiology and Infection · 2019
Infectious diseases · Immunity and vaccination
Citation for The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: A comparative analysis with hepatitis a virus seroprevalence
Smit, G.S.A., Abrams, S., Dorny, P., Speybroeck, N., Devleesschauwer, B., Hutse, V., Jansens, H., Theeten, H., Beutels, P., & Hens, N. (2019) "The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: A comparative analysis with hepatitis a virus seroprevalence." Epidemiology and Infection. 147.
Journal of Theoretical Biology · 2019
Infectious diseases
Citation for The impact of behavioral interventions on co-infection dynamics: An exploration of the effects of home isolation
Hendrickx, D.M., Abrams, S., & Hens, N. (2019) "The impact of behavioral interventions on co-infection dynamics: An exploration of the effects of home isolation." Journal of Theoretical Biology. 476, 5–18.
BMC Medical Research Methodology · 2019
Infectious diseases · Immunity and vaccination · Statistical methods
Citation for Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling
Blaizot, S., Herzog, S.A., Abrams, S., Theeten, H., Litzroth, A., & Hens, N. (2019) "Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling." BMC Medical Research Methodology. 19(1).
The Journal of Infectious Diseases · 2019
Infectious diseases
Citation for Households or Hotspots? Defining Intervention Targets for Malaria Elimination in Ratanakiri Province, Eastern Cambodia
Bannister-Tyrrell, M., Krit, M., Sluydts, V., Tho, S., Sokny, M., Mean, V., Kim, S., Menard, D., Grietens, K.P., Abrams, S., Hens, N., Coosemans, M., Bassat, Q., van Hensbroek, M.B., Durnez, L., & Van Bortel, W. (2019) "Households or Hotspots? Defining Intervention Targets for Malaria Elimination in Ratanakiri Province, Eastern Cambodia." The Journal of Infectious Diseases. 220(6), 1034–1043.
Statistical Methods in Medical Research · 2019
Statistical methods
Citation for Correlated gamma frailty models for bivariate survival time data
Martins, A., Aerts, M., Hens, N., Wienke, A., & Abrams, S. (2019) "Correlated gamma frailty models for bivariate survival time data." Statistical Methods in Medical Research. 28(10-11), 3437–3450.
Eurosurveillance · 2018
Infectious diseases
Citation for Resurgence risk for measles, mumps and rubella in France in 2018 and 2020
Béraud, G., Abrams, S., Beutels, P., Dervaux, B., & Hens, N. (2018) "Resurgence risk for measles, mumps and rubella in France in 2018 and 2020." Eurosurveillance. 23(25).
Biometrics · 2017
Statistical methods
Citation for Parametric overdispersed frailty models for current status data
Abrams, S., Aerts, M., Molenberghs, G., & Hens, N. (2017) "Parametric overdispersed frailty models for current status data." Biometrics. 73(4), 1388–1400.
Journal of the Royal Statistical Society: Series C (Applied Statistics) · 2017
Infectious diseases · Immunity and vaccination · Statistical methods
Citation for Modelling time varying heterogeneity in recurrent infection processes: an application to serological data
Abrams, S., Wienke, A., & Hens, N. (2017) "Modelling time varying heterogeneity in recurrent infection processes: an application to serological data." Journal of the Royal Statistical Society: Series C (Applied Statistics). 67(3), 687–704.
Epidemiology and Infection · 2017
Infectious diseases · Statistical methods
Citation for Estimating age-time-dependent malaria force of infection accounting for unobserved heterogeneity
MUGENYI, L., ABRAMS, S., & HENS, N. (2017) "Estimating age-time-dependent malaria force of infection accounting for unobserved heterogeneity." Epidemiology and Infection. 145(12), 2545–2562.
Vaccine · 2016
Infectious diseases · Immunity and vaccination
Citation for Inferring rubella outbreak risk from seroprevalence data in Belgium
Abrams, S., Kourkouni, E., Sabbe, M., Beutels, P., & Hens, N. (2016) "Inferring rubella outbreak risk from seroprevalence data in Belgium." Vaccine. 34(50), 6187–6192.
Medecine et Maladies Infectieuses · 2016
Infectious diseases
Citation for COL 2-03 - Resurgence risk for measles, mumps and rubella in France in 2016
Béraud, G., Abrams, S., Levy-Bruhl, D., Antona, D., Beutels, P., Dervaux, B., & Hens, N. (2016) "COL 2-03 - Resurgence risk for measles, mumps and rubella in France in 2016." Medecine et Maladies Infectieuses. 46(4), 4.
Biostatistics · 2015
Infectious diseases · Statistical methods
Citation for Modeling individual heterogeneity in the acquisition of recurrent infections: an application to parvovirus B19
Abrams, S., & Hens, N. (2015) "Modeling individual heterogeneity in the acquisition of recurrent infections: an application to parvovirus B19." Biostatistics. 16(1), 129–142.
Eurosurveillance · 2015
Infectious diseases · Immunity and vaccination
Citation for Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013
Hens, N., Abrams, S., Santermans, E., Theeten, H., Goeyvaerts, N., Lernout, T., Leuridan, E., Van Kerckhove, K., Goossens, H., Van Damme, P., & Beutels, P. (2015) "Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013." Eurosurveillance. 20(1).
American Journal of Epidemiology · 2014
Infectious diseases · Immunity and vaccination
Citation for Assessing Mumps Outbreak Risk in Highly Vaccinated Populations Using Spatial Seroprevalence Data
Abrams, S., Beutels, P., & Hens, N. (2014) "Assessing Mumps Outbreak Risk in Highly Vaccinated Populations Using Spatial Seroprevalence Data." American Journal of Epidemiology. 179(8), 1006–1017.
No publications match these filters. Try a broader search or clear the filters.